Showing results (2761-2770 of 11,043) with videos related to
Sort By:
Pageof 1,105
Journal of the National Cancer Institute|July 30, 2026
Early discontinuation of chemotherapy in older adults with early breast cancer: results from the prospective multicenter HOPE studyJingran Ji, Can-Lan Sun, William Dale, et al.Journal of the National Cancer Institute|August 4, 2026
The Real-World use of McGill interactive pediatric OncoGenetic guidelines (MIPOGG): A Cross-Sectional surveyJavier Higuera-Ornelas, Maria Rueda Martinez, Lara Reichman, et al.Journal of the National Cancer Institute|August 8, 2026
Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecanMing Zhao, Bailiang Wang, Kurt W Evans, et al.Journal of the National Cancer Institute|August 13, 2026
Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumorsRicardo Cortez Cardoso Penha, Shama Virani, Jeremiah R Holt, et al.Journal of the National Cancer Institute|August 23, 2026
Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-Derived external control armsMorteza Raeisi, Thierry André, Qian Shi, et al.Journal of the National Cancer Institute|August 19, 2026
Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancerPietro Lapidari, Maryam Lustberg, Julie Havas, et al.Journal of the National Cancer Institute|August 19, 2026
Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-AnalysisDavide Massa, Edoardo Chiappe, Virginia Delucchi, et al.Journal of the National Cancer Institute|August 17, 2026
Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort studyThomas Frisell, Johan Askling, Joakim Dillner, et al.Journal of the National Cancer Institute|August 24, 2026
Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and managementMaria I Carlo, Andrew Schroeder, Jie Liu, et al.Journal of the National Cancer Institute|August 24, 2026
Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancerVanita Noronha, Nandini Menon, Minit Shah, et al.Pageof 1,105